High-dose methotrexate-based regimens with or without vincristine for the treatment of primary central nervous system lymphoma

BACKGROUND: Primary central nervous system lymphoma (PCNSL) is a rare malignancy with few treatment options. One regimen used for induction is rituximab, high-dose methotrexate (HD-MTX), procarbazine, and vincristine (R-MPV). A common institutional practice is removing vincristine (VCR) from this re...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neurooncol Adv
Prif Awduron: Freeman, Tracelyn, Legasto, Carlo S, Schickli, M Alexandra, McLaughlin, Eric M, Giglio, Pierre, Puduvalli, Vinay, Gonzalez, Javier
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2020
Pynciau:
Clinical Investigations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372924/
https://ncbi.nlm.nih.gov/pubmed/32715297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa077
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg